Last updated: July 11, 2026

Application No. 19/570,016

Untitled Application

Unknown

Filed

Priority

Apr 23, 2014 — provisional 61/983,415 +6 more

Examiner

WEHBE, ANNE MARIE SABRINA

Art Unit

Tech Center

Juno Therapeutics, Inc.

Assignee

Juno Therapeutics Inc.

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +42.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 693 resolved cases, 2023–2026

Examiner Intelligence

WEHBE, ANNE MARIE SABRINA View full profile →

Grants 58% of resolved cases

Career Allowance Rate

399 granted / 693 resolved

-2.4% vs TC avg

Strong +42% interview lift

Without

With

+42.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 7m

Avg Prosecution

45 currently pending

Career history

737

Total Applications

across all art units

Statute-Specific Performance

§101

1.1%

-38.9% vs TC avg

§103

53.0%

+13.0% vs TC avg

§102

9.5%

-30.5% vs TC avg

§112

21.9%

-18.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 693 resolved cases

Prosecution Timeline

May 07, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/047,233

Patent 12653904

TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)

3y 8m to grant Granted Jun 16, 2026

16/472,794

Patent 12642872

VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE

6y 11m to grant Granted Jun 02, 2026

17/734,392

Patent 12628801

HUMANIZED UNIVERSAL LIGHT CHAIN MICE

4y 0m to grant Granted May 19, 2026

17/040,017

Patent 12622935

MODIFIED ONCOLYTIC ADENOVIRUSES

5y 7m to grant Granted May 12, 2026

17/042,865

Patent 12624367

AAV6 VARIANTS

5y 7m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

99%

With Interview (+42.3%)

3y 7m

Median Time to Grant

Low

PTA Risk

Based on 693 resolved cases by this examiner. Grant probability derived from career allowance rate.